• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste.禁食和餐后状态下口服地高辛后的血浆浓度。 不过你提供的原文“postprandial ste”似乎有误,推测应该是“postprandial state”(餐后状态) 。
Br Med J. 1971 Feb 13;1(5745):380-1. doi: 10.1136/bmj.1.5745.380.
2
Application of individualized digoxin dosage regimens to canine therapeutic digitalization.
Am J Vet Res. 1980 Aug;41(8):1238-42.
3
[Biological availability of digoxin and beta-methyl-digoxin administered in the fasting state or after meals].[空腹或餐后服用地高辛和β-甲基地高辛的生物利用度]
Schweiz Med Wochenschr. 1981 Sep 26;111(39):1434-40.
4
Pharmacokinetics of digoxin: interpreting bioavailability.地高辛的药代动力学:生物利用度的解读
Br Med J. 1973 Oct 20;4(5885):132-4. doi: 10.1136/bmj.4.5885.132.
5
[Preoperative digitalization. Measurement of digoxin plasma levels (author's transl)].[术前数字化。地高辛血浆水平的测定(作者译)]
Anaesthesist. 1976 Sep;25(9):405-17.
6
Fasting and postprandial absorption of digoxin from a microencapsulated formulation.地高辛微囊制剂的空腹及餐后吸收情况
Eur J Clin Pharmacol. 1983;25(2):207-10. doi: 10.1007/BF00543792.
7
Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.“新”“旧”地高辛吸收、血药浓度及尿排泄的对比研究。
Br Med J. 1973 Mar 24;1(5855):695-7. doi: 10.1136/bmj.1.5855.695.
8
Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.地高辛的最大肠道吸收及其与稳态血药浓度的关系。
Br Heart J. 1975 Feb;37(2):203-8. doi: 10.1136/hrt.37.2.203.
9
Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.
Clin Pharmacol Ther. 1974 Sep;16(3):444-8. doi: 10.1002/cpt1974163part1444.
10
[Influence of antacids on plasma concentration of digoxin in man (author's transl)].
Dtsch Med Wochenschr. 1976 Jan 23;101(4):106-8. doi: 10.1055/s-0028-1104044.

引用本文的文献

1
Digoxin therapy: textbooks, theory and practice.地高辛治疗:教科书、理论与实践。
Br J Clin Pharmacol. 1976 Aug;3(4):639-48. doi: 10.1111/j.1365-2125.1976.tb04888.x.
2
Food-drug interactions.食物-药物相互作用
Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005.
3
Effect of food on the absorption of hydralazine in man.食物对人体中肼屈嗪吸收的影响。
Eur J Clin Pharmacol. 1981;20(1):53-8. doi: 10.1007/BF00554667.
4
A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
5
Fasting and postprandial absorption of digoxin from a microencapsulated formulation.地高辛微囊制剂的空腹及餐后吸收情况
Eur J Clin Pharmacol. 1983;25(2):207-10. doi: 10.1007/BF00543792.
6
An anaesthetic application of serum digoxin radioimmunoassay.血清地高辛放射免疫测定的麻醉应用。
Can Anaesth Soc J. 1972 Jan;19(1):20-34. doi: 10.1007/BF03006904.
7
Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice.居家医疗中老年人肾功能对血浆地高辛水平的影响。
Br Med J. 1972 Feb 5;1(5796):338-41. doi: 10.1136/bmj.1.5796.338.
8
[Bioavailability of digoxin in fixed combinations (author's transl)].地高辛固定复方制剂的生物利用度(作者译)
Klin Wochenschr. 1974 Jul 1;52(13):637-9. doi: 10.1007/BF01468799.
9
Biological availability of digoxin from Lanoxin produced in the United Kingdom.英国生产的地高辛片剂(商品名:Lanoxin)中地高辛的生物利用度。
Br Med J. 1973 Nov 10;4(5888):323-6. doi: 10.1136/bmj.4.5888.323.
10
Pharmacokinetics of digoxin: interpreting bioavailability.地高辛的药代动力学:生物利用度的解读
Br Med J. 1973 Oct 20;4(5885):132-4. doi: 10.1136/bmj.4.5885.132.

本文引用的文献

1
Tritiated digoxin studies in human subjects.人体受试者中的氚标记地高辛研究。
Arch Intern Med. 1961 Oct;108:531-9. doi: 10.1001/archinte.1961.03620100023004.
2
Clinical pharmacology of digoxin.地高辛的临床药理学
J Pharmacol Exp Ther. 1953 Sep;109(1):45-57.
3
The distribution and concentration of tritiated digoxin in human tissues.氚标记地高辛在人体组织中的分布与浓度。
Ann Intern Med. 1967 Jan;66(1):116-24. doi: 10.7326/0003-4819-66-1-116.
4
Administration of tritiated digoxin with and without a loading dose. A metabolic study.给予和不给予负荷剂量的氚标记地高辛。一项代谢研究。
Circulation. 1966 Nov;34(5):865-74. doi: 10.1161/01.cir.34.5.865.
5
Plasma digoxin concentrations in patients with atrial fibrillation.心房颤动患者的血浆地高辛浓度。
Br Med J. 1970 Aug 22;3(5720):429-32. doi: 10.1136/bmj.3.5720.429.
6
Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.采用放射免疫分析法测定治疗性和中毒性血清地高辛浓度。
N Engl J Med. 1969 Nov 27;281(22):1212-6. doi: 10.1056/NEJM196911272812203.

禁食和餐后状态下口服地高辛后的血浆浓度。 不过你提供的原文“postprandial ste”似乎有误,推测应该是“postprandial state”(餐后状态) 。

Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste.

作者信息

White R J, Chamberlain D A, Howard M, Smith T W

出版信息

Br Med J. 1971 Feb 13;1(5745):380-1. doi: 10.1136/bmj.1.5745.380.

DOI:10.1136/bmj.1.5745.380
PMID:5100372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1795028/
Abstract

After the oral administration of 0.5 mg of digoxin in tablet form to fasting subjects peak plasma levels were reached in 30 to 60 minutes. Levels then fell to reach a plateau at six to eight hours. When the same dose was given after food the peak plasma concentrations were significantly lower, but the concentrations reached in samples obtained from two to eight hours after the dose did not differ appreciably from corresponding samples obtained in the fasting experiments.In a four-week cross-over study of 21 patients on maintenance therapy, digoxin taken regularly in the fasting state produced plasma concentrations similar to those obtained when the drug was taken after meals.The rapid appearance of digoxin in the blood suggests that the oral route of administration is adequate for most patients who require rapid digitalization, and the timing of maintenance dosage in relation to meals is unimportant.

摘要

给空腹受试者口服0.5毫克片剂地高辛后,30至60分钟达到血浆峰值水平。随后水平下降,在6至8小时达到平稳状态。进食后给予相同剂量时,血浆峰值浓度显著降低,但给药后2至8小时采集的样本中的浓度与空腹实验中相应样本的浓度并无明显差异。在一项针对21名接受维持治疗患者的为期四周的交叉研究中,空腹状态下定期服用地高辛产生的血浆浓度与餐后服用该药时获得的浓度相似。地高辛在血液中快速出现表明,口服给药途径对大多数需要快速洋地黄化的患者来说是足够的,维持剂量与进餐时间的关系并不重要。